Clinical trials
Recruiting Carcinoma, Non-Small-Cell Lung trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 22 |
| 2025 | 27 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 90 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Bristol-Myers Squibb | 8 |
| Merck Sharp & Dohme LLC | 8 |
| Pfizer | 5 |
| BioNTech SE | 4 |
| AbbVie | 3 |
| Eli Lilly and Company | 3 |
| Janssen Research & Development, LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| Pierre Fabre Medicament | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 90 |
| Lung Neoplasms | 24 |
| Colorectal Neoplasms | 8 |
| Melanoma | 8 |
| Carcinoma | 7 |
| Neoplasm Metastasis | 7 |
| Neoplasms | 7 |
| Lung Diseases | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Endometrial Neoplasms | 5 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.